Bulletin
Investor Alert

Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

76.74

Change

0.00 0.00%

Volume

Volume 51,211

Jan 24, 2020, 5:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204510994/composite

Previous close

$ 78.24

$ 76.74

Change

-1.50 -1.92%

Day low

Day high

$75.83

$78.76

Open
Open: 78.15

52 week low

52 week high

$72.00

$96.79

Open

Market cap

$16.53B

Average volume

1.54M

P/E ratio

41.19

Rev. per Employee

$1.38M

EPS

1.86

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Incyte stock price target cut to $74 from $85 at BMO Research

    10:43 a.m. Jan. 3, 2020

    - Tomi Kilgore

  2. Incyte stock slammed after study fails to hit goal

    4:40 p.m. Jan. 2, 2020

    - Jeremy C. Owens

  3. The 3 Best-Performing Health Care Stocks of 2019 So Far

    7:30 a.m. Nov. 28, 2019

    - Barron's Online

  4. Incyte rerpots positive results in trial of treatment for GVHD

    6:04 a.m. Oct. 16, 2019

    - Ciara Linnane

  5. Incyte shares up 1.2% premarket

    6:05 a.m. Oct. 16, 2019

    - Ciara Linnane

  6. European Conference Highlights Cancer-Drug Developments

    6:00 a.m. Oct. 3, 2019

    - Barron's Online

  7. The 3 Best Health-Care Stocks This Month. And the Worst

    5:00 a.m. Sept. 30, 2019

    - Barron's Online

  8. A Big Cancer Conference Could Yield Breakthroughs

    6:10 a.m. Oct. 1, 2019

    - Barron's Online

  9. Incyte upgraded to outperform from perform at Oppenheimer

    7:31 a.m. Sept. 5, 2019

    - Tomi Kilgore

  10. Incyte stock price target raised to $100 from $85 at Oppenheimer

    7:31 a.m. Sept. 5, 2019

    - Tomi Kilgore

  11. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. MorphoSys and Incyte team up to advance tafasitamab in $2B deal

    4:50 p.m. Jan. 16, 2020

    - Seeking Alpha

  2. Biotech Bonanza: 2020 Outlook In An Election Year

    4:15 p.m. Jan. 8, 2020

    - Seeking Alpha

  3. Black Diamond Therapeutics Begins IPO Effort

    3:35 p.m. Jan. 6, 2020

    - Seeking Alpha

  4. Company News For Jan 6, 2020

    10:06 a.m. Jan. 6, 2020

    - Zacks.com

  5. Stock Market Today: Is the Rally Ruined?; Tesla’s New Record

    4:26 p.m. Jan. 3, 2020

    - InvestorPlace.com

  6. Incyte's pain is Equillium's gain, up 12%

    3:28 p.m. Jan. 3, 2020

    - Seeking Alpha

  7. OCUL, ACOR, INCY and DPW among midday movers

    12:41 p.m. Jan. 3, 2020

    - Seeking Alpha

  8. Goldman likes Humana in premarket analyst action

    7:05 a.m. Jan. 3, 2020

    - Seeking Alpha

  9. Incyte Corporation: Wait And Watch

    7:44 a.m. Dec. 29, 2019

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/incy

Press Releases on INCY

  1. Incyte to Report Fourth Quarter and Year-End Financial Results

    8:00 a.m. Jan. 23, 2020

    - BusinessWire - BZX

  2. Nasdaq 100 Movers: ALXN, AAL

    10:21 a.m. Jan. 14, 2020

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.